ExodusPoint Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

ExodusPoint Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,839	Closed	-$75K	–	2485
2022 Q2	$75K	Sell	10,839 -4,866	-31%	-$34.1K	﹤0.01%	1767
2022 Q1	$146K	Buy	15,705 +4,142	+36%	+$44.1K	﹤0.01%	1965
2021 Q4	$164K	Sell	11,563 -10,664	-48%	-$185K	﹤0.01%	1865
2021 Q3	$515K	Buy	+22,227	New	+$526K	0.01%	1360

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

ExodusPoint Capital Management's FMTX Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 10,839 shares — an estimated $75K sold.

ExodusPoint Capital Management first reported a position in FMTX in Q3 2021 and held it in 4 quarters. The position peaked at $515K in Q3 2021. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

ExodusPoint Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 10,839 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $75K.
ExodusPoint Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
ExodusPoint Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $515K in Q3 2021.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.